1. Home
  2. AGRO vs AVLN Comparison

AGRO vs AVLN Comparison

Compare AGRO & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adecoagro S.A.

AGRO

Adecoagro S.A.

SELL

Current Price

$10.54

Market Cap

1.6B

ML Signal

SELL

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

SELL

Current Price

$23.74

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AGRO
AVLN
Founded
2002
2011
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
AGRO
AVLN
Price
$10.54
$23.74
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$13.40
★ $61.80
AVG Volume (30 Days)
★ 532.3K
294.8K
Earning Date
11-12-2026
11-25-2026
Dividend Yield
★ 3.40%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$56.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.52
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.89
$24.14
52 Week High
$15.89
$40.17

Technical Indicators

Market Signals
Indicator
AGRO
AVLN
Relative Strength Index (RSI) 45.35 26.31
Support Level $9.82 N/A
Resistance Level $10.91 $30.45
Average True Range (ATR) 0.35 1.69
MACD -0.02 -0.32
Stochastic Oscillator 52.02 5.70

Price Performance

Historical Comparison
AGRO
AVLN

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: